Also trades as: PPCBD (OTC) · $vol 0M
PPCB NASDAQ
Propanc Biopharma, Inc.
1W: -19.5%
1M: -50.7%
3M: -73.0%
YTD: -11.2%
1Y: -70.2%
3Y: -100.0%
5Y: -99.0%
$0.51
+0.01 (+1.30%)
Weekly Expected Move ±14.3%
$0
$0
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Balance Sheet Trends
Total Assets
$13M
-34.9% ▼
5Y CAGR: +296.1%
Total Liabilities
$3M
-41.0% ▼
5Y CAGR: +1.9%
Shareholders Equity
$9M
-32.4% ▼
Cash & Investments
$832K
+6782.9% ▲
5Y CAGR: +226.1%
Total Debt
$48K
-97.2% ▼
5Y CAGR: -41.1%
Net Debt
-$784K
-145.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $4K | $10K | $21K | $12K | $832K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $4K | $10K | $21K | $12K | $832K |
| Net Receivables | $2K | $3K | $3K | $5K | $14K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $1K | $8M | $8M |
| Total Current Assets | $15K | $19K | $25K | $8M | $9M |
| Property, Plant & Equip. | $65K | $39K | $18K | $59K | $45K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $2K | $2K | $29K | $11M | $4M |
| Total Non-Current Assets | $67K | $41K | $47K | $11M | $4M |
| Total Assets | $82K | $60K | $72K | $20M | $13M |
| — Liabilities — | |||||
| Accounts Payable | $943K | $967K | $1M | $1M | $1M |
| Short-Term Debt | $978K | $505K | $870K | $2M | $24K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $567K | $1M | $773K | $3M | $2M |
| Total Current Liabilities | $3M | $3M | $4M | $6M | $3M |
| Long-Term Debt | $0 | $0 | $59K | $106K | $24K |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $42K | $19K | $59K | $147K | $24K |
| Total Liabilities | $3M | $3M | $4M | $6M | $3M |
| — Equity — | |||||
| Common Stock | $240 | $8K | $479K | $12K | $4K |
| Retained Earnings | -$62M | -$65M | -$67M | -$126M | -$144M |
| Accumulated OCI | $1M | $1M | $1M | $1M | $1M |
| Total Stockholders Equity | -$3M | -$3M | -$4M | $14M | $9M |
| Total Liabilities & Equity | $82K | $60K | $72K | $20M | $13M |
| — Key Metrics — | |||||
| Total Debt | $1M | $546K | $948K | $2M | $48K |
| Net Debt | $1M | $536K | $927K | $2M | -$784K |
| Total Investments | $0 | $0 | $0 | $0 | $0 |